Variation in presentation and presence of DNA adducts and p53 mutations in patients with endemic nephropathy-an environmental form of the aristolochic acid nephropathy

Kidney and Blood Pressure Research

Volumn 37, Issue 1, 2013, Pages 1-8

  Karanović, Sandra ^a   Lela, Ivana Vuković ^a   Jelaković, Bojan ^a   Dickman, Kathleen G ^b   Peić, Anamarija Kovač ^c   Dittrich, Damir ^c   Knežević, Matej ^c   Matijević, Vesna ^d   Fernandes, Andrea S ^b   Miller, Frederick ^e  

^a KBC Zagreb   (Croatia)

^b STONY BROOK UNIVERSITY   (United States)

^c DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

^d Outpatient Clinic for General Medicine   (Croatia)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

Aristolochic acid; Endemic nephropathy; Urothelial cell cancer

Indexed keywords

ARISTOLOCHIC ACID; ARISTOLOLACTAM; CISPLATIN; CREATININE; DOXORUBICIN; METHOTREXATE; PROTEIN P53; VINBLASTINE;

ADULT; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; BLADDER CANCER; CASE REPORT; COLON CANCER; CREATININE BLOOD LEVEL; DISEASE COURSE; DNA ADDUCT; DNA DETERMINATION; DNA REPAIR; ECHOGRAPHY; ENDEMIC NEPHROPATHY; GENE MUTATION; GENETIC POLYMORPHISM; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; INTERSTITIAL NEPHRITIS; INTRAVENOUS UROGRAPHY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUMOR; MALE; MULTIPLE CYCLE TREATMENT; NEPHROURETERECTOMY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECURRENT CANCER; RETROGRADE PYELOGRAPHY; URETER DILATATION; UROGENITAL TRACT TUMOR; CANCER CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; DETOXIFICATION; END STAGE RENAL DISEASE; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; FAMILY HISTORY; GENETIC SCREENING; HEMATURIA; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS; KIDNEY PELVIS CANCER; LOW BACK PAIN; METABOLIC ACTIVATION; MIDDLE AGED; POSTOPERATIVE CARE; QUESTIONNAIRE; TRANSITIONAL CELL CARCINOMA; URETER CARCINOMA; URINALYSIS;

ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; GENES, P53; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION;

EID: 84874234439     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000343394     Document Type: Article

References (26)

1. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-391.
2. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL: Identification of aristolochic acid in Chinese herbs. Lancet 1994;343:174.
3. Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C: Chinese herbs nephropathy: a clue to Balkan endemic nephropathy. Kidney Int 1994;45:1680-1688.
4. Vanherweghem JL: Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998;4:9-13.
5. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-1692.
6. Cosyns J-P, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Stihou C: Urothelial lessons in Chinese-herb nephropathy. Am J Kidney Dis 1999;33:1011-1017.
7. Stiborova M, Frei E, Schmeiser HH: Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int 2008;73:1209-1211.
8. Aristolochic acids, In: National Toxicology Program Report on Carcinogens 12th Ed. (2011) US Dept Health and Human Services, Public Health Service, Research, Triangle Park, North Carolina.
9. Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, Grollman AP, Jelakovi B: Endemic nephropathy: The case for chronic poisoning by Aristolochia. Croat Med J 2005;46:116-125.
10. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukeli M, Jelakovi B: Aristolochic acid and the etiology of (Balkan) endemic nephropathy. Proc Natl Acad Sci USA 2007;104:12129-12134.
11. Grollman AP, Jelakovi B:. Role of Environmantal Toxins in Endemic (Balkan) Nephropathy. J Am Soc Nephrol 2007;18:2817-2823.
12. Jelakovi B, Karanovi S, Vukovi-Lela I, Miller F, Edwards KL, Nikoli J, Tomi K, Slade N, Brdar B, Turesky RJ, Stipani Z, Dittrich D, Grollman AP, Dickman KG: Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 2012;81:559-567.
13. Jeovi S, Mileti-Medved M: Epidemiological features of endemic nephropathy in focal area of Brodska Posavina, Croatia. In: vorisec, eovi, Stavljeni-Rukavina, eds. Endemic nephropathy in Croatia. Zagreb: Academia Croatica scientiarum medicarum. 1996, p 7-21.
14. Petroni VJ, Bukurov NS, Djoki MR, Milenkovi DZ, Vuksanovi AM, Avramovi AD, Nale DP: Balkan endemic nephropathy and papillary transitional cell tumors of the renal pelvis and ureters. Kidney Int Suppl 1991;34:S77-S79.
15. Radovanovi Z: Epidemiology and aethiology of endemic nephropathy. In: Radovanovic Z, Sindjic M, Polenkovic M, Djukanovic Lj, Petronic V, eds. Endemic nephropathy. Belgrade: Office for textbooks and teaching aids. 2000, p 22-135.
16. Grollman AP, Scarborough J, Jelakovi B: Chapter 7 Aristolochic Acid Nephropathy: An Environmental and Iatrogenic Disease, In: James C. Fishbein, eds, Advances in Molecular Toxicology, New York,Elsevier, 2009, Vol 3, p 211-227.
17. Debelle FD, Vanherweghem JL, Nortier JL: Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008;74:158-169.
18. Fistrek M, Kova-Pei A, Kos J, Pein I, Bariši M, Hadžibegovi I, ani A, Miši M, Pavlovi I, Dika Z, Mileti-Medved M, Cvitkovi A, Bistrovi D, Grollman AP, Jelakovi B: Ingestion of herbal tea in Croatian endemic area, International workshop on diagnostic criteria for endemic nephropathy, 5th Croatian congress on nephrology, dyalisis and transplantation with international participation, Bra, Croatia 2008.
19. Hranjec T, Kova A,Kos J,Dika Z, Brzi I, MaoW, Chen JJ, Grollman AP, Jelakovi B: Dietary exposure to Aristolochia clematitis is a risk factor for endemic nephropathy. Coll Antropol 2006;30:S37.
20. Lord GM, Hollstein M, Arlt VM, Roufosse C, Pusey CD, Cook T, Schmeiser HH: DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am J Kidney Dis 2004;43:e11-e17.
21. Vorisec D, Eovi S, Boršo G, Stavljeni Rukavina A: Endemic Nephropathy in Croatia. Clin Chem Lab Med 1998;36:271-277.
22. Bukvi D, Mari I, Arsenovi A, Jankovi S, Djukanovi L: Prevalence of Balkan endemic nephropathy has not changed since 1971 in the Kolubara region in Serbia. Kidney Blood Press Res 2007;30:117-123.
23. Nortier JL, Schmeiser HH, Muniz Martinez MC, Arlt VM, Vervaet C, Garbar CH, Daelemans P, Vanherweghem JL: Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 2003;18:426-428.
24. Lo SH, Mo KL, Wong KS, Poon SP, Chan CK, Lai CK, Chan A: Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2004;19:1913-1915.
25. Miši M, Vukeli M, Jakovina K, Medverec Z, Jakovina T, Stani G, Jelakovi B: Characteristics of urinary tract carcinomas in patients from endemic nephropathy and non-endemic areas in Slavonski Brod county in a 6-year period. Coll Antropol 2006;30:S67.
26. Muniz Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL: Progression rate of Chinese herb nephropathy: impact of of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002;17:408-412.